Updated 1 September 2026
We carried out an announced comprehensive assessment of ADHD360 on 15th September 2026. We also carried out additional offsite activity, with final interviews completed on 29th September 2026. We announced the assessment to ensure we had access to the evidence required and could speak with staff.
The provider was previously inspected 25th August 2023 and was rated as requires improvement overall.
ADHD360 provides specialist services for people with attention deficit hyperactivity disorder (ADHD), including screening, assessment, diagnosis, treatment and ongoing support. The provider describes its service as UK-wide and provides services for adults, young adults and children.
The service supports privately funded and NHS-funded patients. NHS-funded care is provided through commissioned NHS arrangements and the NHS right to choose (RTC) pathway. The provider worked with NHS organisations and holds contracts to deliver ADHD assessment, diagnosis and treatment services for NHS patients in England.
The service had a registered manager and was registered with the Care Quality Commission to provide the regulated activity Treatment of disease, disorder or injury.
Care and treatment were predominantly delivered remotely. People completed an online screening process and, where appropriate, attended an assessment by video consultation with an ADHD360 clinician. Where a diagnosis of ADHD was made, a personalised treatment plan was developed. This could include medication, where clinically appropriate, medication optimisation and regular follow-up. ADHD360 stated that their treatment pathway included 12 months of continuous care.
The service had different access arrangements for privately funded and NHS-funded patients. People accessing the service through the NHS RTC pathway required a GP referral. At the time of our review of the provider's published information, RTC referrals were accepted for children aged 8 years and over and adults aged 16 years and over.
Waiting times for NHS RTC referrals varied according to demand, availability, capacity and local Integrated Care Board (ICB) commissioning arrangements. The provider published estimated waiting times and information about specific ICB requirements. At the time of our review, the provider reported that high demand for ADHD services in some areas, together with local NHS commissioning and capacity restrictions, could result in people waiting longer to access the service.
Following diagnosis, people received ongoing treatment and support. This included personalised treatment planning, medication and dose optimisation where appropriate, and regular follow-up. Once treatment was stable and optimised, people could also access optional additional support, including counselling, coaching and peer support groups.
ADHD360 worked alongside NHS partners to provide services to people accessing care through RTC and through other commissioned NHS arrangements. The provider's published information stated that it also undertook contracted NHS activity within specific geographical areas.
Mental Health Act and Mental Capacity Act Compliance Summary
ADHD360 provided independent ADHD assessment, diagnosis and treatment services for children and adults. It did not provide inpatient care or treat people detained under the Mental Health Act 1983. Where people required assessment or treatment under the Act, staff supported them to access appropriate mental health or emergency services.
The provider had a Mental Capacity Act policy that was accessible to staff. Staff understood the principles of the Act and how to apply them to support lawful and person-centred decision-making. This included considering capacity in relation to specific decisions, supporting people to understand relevant information and recording best-interest decisions where required.
Mental Capacity Act training formed part of the provider’s core mandatory training programme. Staff knew how to obtain and record consent during assessment, treatment, medication reviews and information sharing, and how to seek advice from clinical leaders when concerns about a person’s capacity were identified.
People’s experienceWe spoke with 4 adults who used the service and gathered feedback by telephone. Overall, people were positive about their experience and described staff as professional, knowledgeable, caring and responsive. People felt respected, listened to and that staff genuinely wanted the best outcomes for them. One person told us, “I really appreciate their knowledge.”
Care was patient-led and tailored to their individual needs. One person described how they and other family members received care from the service and all had different treatment plans and medicines according to their individual needs. They felt sufficient time was taken to identify the most appropriate medication. Another person told us staff did not pressure them to take medication and instead, focused on ensuring treatment was safe and appropriate for them.
People described clinicians as knowledgeable and said they asked relevant questions during assessments. They felt involved in decisions about their care and treatment and reported no concerns about the assessment process. People also described positive experiences of ongoing monitoring, including contact from the team approximately every 4 to 6 weeks, where applicable, and said staff were responsive and accessible when they needed additional support.
People told us the providers patient portal and app worked well, and they had experienced no difficulties using them. They received email reminders when information or monitoring arrangements needed to be updated, which supported their engagement with treatment. ADHD360 provided a patient portal as part of its service and described ongoing support following assessment and diagnosis.
People compared their experiences positively with other services. One person considered the treatment better than their previous NHS experience, while another compared the care favourably with experiences friends had reported with other private providers. One person identified NHS waiting times as a concern because a family member remained on an NHS waiting list; this did not relate to a concern about the care provided by ADHD360.
People accessing the service were at different stages of the care pathway, including awaiting medication or further treatment following assessment. They reported no concerns about the service while waiting. One person was both a staff member and a patient and was awaiting the next stage of their pathway.
People expressed confidence in the service and reported no significant concerns about the care they had received and said they would be happy to recommend the service to friends or family. Their feedback showed that people experienced individualised, patient-led care, knowledgeable and compassionate staff, responsive communication and involvement in decisions about their treatment.